Kimialysis an innovative industrial biosensing company that leverages its proprietary K-One surface chemistry, with the mission of setting new standards in biosensing by delivering the most robust and reproducible data, because achieving high sensitivity means nothing if the data are not reliable. We enable R&D teams worldwide to tackle ambitious projects and develop tomorrow’s diagnostics and therapeutics.
Over the past five years, we’ve worked with partners across industry and academia to demonstrate the strength of our technology and approach. To date, we’ve delivered 100+ projects on real-world, complex applications, and we are now entering scale-up and industrialization programs with clients.
We are also proud to have completed a second fundraising round, larger than the first — a testament to our investors’ continued confidence in what we’re building. In the years ahead, we will turn that confidence into impact, becoming a trusted name across the entire biosensing ecosystem.
To understand why Kimialys and K-One exist, and how they may be relevant to your work, see the document below:
A strong technology, however game-changing it may be, finds its true strength in the dedicated team behind it.
30+
Projects worldwide
+130%
Team growth year-to-year
$3M
Secured in private and public financing
8 phDs
Experts in chemistry for biodetection
Good work and positivity!